首页> 外文期刊>Regulatory peptides. >Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states.
【24h】

Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states.

机译:Exendin-4在胰岛素抵抗和2型糖尿病状态下发挥成骨作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Poor control of glucose homeostasis accounts for diabetes-related bone loss. Incretins - GLP-1 and GIP - have been proposed to affect bone turnover. GLP-1, apart from its anti-diabetic and other actions, has shown to exert a bone anabolic effect in streptozotocin-induced type 2 diabetic (T2D) and fructose-induced insulin-resistant (IR) rats. Exendin-4 (Ex-4), a peptide of non-mammalian nature, is sharing with GLP-1 part of its structural sequence, and also several glucoregulatory effects in mammals in an even more efficient manner. We have explored the effect of continuous administration (3 days by osmotic pump) of Ex-4 or saline (control) on bone turnover factors and bone structure in T2D and IR rats, compared to N, and the possible interaction of Ex-4 with the Wnt signalling pathway. Blood was taken before and after treatment for plasma measurements; tibiae and femurs were collected for gene expression of bone markers (RT-PCR) and structure (microCT) analysis; we also measured the mRNA levels of LRP5 - an activator of the Wnt pathway - and those of DKK1 and sclerostin (SOST) - both blockers of LRP5 activity. Compared to N-control, plasma glucose and insulin were respectively higher and lower in T2D; osteocalcin (OC) and tartrate-resistant alkaline phosphatase 5b (TRAP5b) were lower; after Ex-4, these turnover markers were further reduced in T2D and IR, while TRAP5b increased in N. Bone OC, osteoprogeterin (OPG) and receptor activator of NF-kB ligand (RANKL) mRNA were lower in T2D and IR; Ex-4 increased OC in all groups and OPG in N and IR, reduced RANKL in N and T2D but increased it in IR; the LRP5/DKK1 and LRP5/SOST mRNA ratios were similarly decreased in T2D, but in IR, the latter ratio was reduced while the former was increased; after Ex-4, both ratios augmented in N, and that of LRP5/DKK1 tended to normalize in T2D and IR. In conclusion, Ex-4 exerts osteogenic effects in T2D and IR models, and interacts with the Wnt pathway to promote bone formation.
机译:葡萄糖稳态的控制不佳是与糖尿病有关的骨质流失的原因。已经提出了肠抑素-GLP-1和GIP-影响骨转换。 GLP-1除具有抗糖尿病和其他作用外,还显示在链脲佐菌素诱导的2型糖尿病(T2D)和果糖诱导的胰岛素抵抗(IR)大鼠中发挥骨合成代谢作用。 Exendin-4(Ex-4)是一种非哺乳动物的肽,与其结构序列的GLP-1部分共享,并且以更有效的方式与哺乳动物中的多种糖调节作用共有。我们研究了连续施用Ex-4或盐水(对照)(通过渗透泵3天)对T2D和IR大鼠的骨转换因子和骨结构(与N相比)的影响,以及Ex-4与Wnt信号通路。在治疗前后采集血液以进行血浆测量;收集胫骨和股骨用于骨标志物的基因表达(RT-PCR)和结构(microCT)分析。我们还测量了LRP5的mRNA水平(这是Wnt途径的激活剂)以及DKK1和硬化蛋白(SOST)的mRNA水平,两者都是LRP5活性的阻断剂。与N-control相比,T2D患者的血浆葡萄糖和胰岛素分别升高和降低。骨钙素(OC)和抗酒石酸碱性磷酸酶5b(TRAP5b)较低;在Ex-4之后,这些转换标记在T2D和IR中进一步降低,而TRAP5b在N.中升高。在T2D和IR中,骨OC,骨蛋白(OPG)和NF-kB配体受体激活剂(RANKL)mRNA降低。 Ex-4在所有组中增加OC,在N和IR中增加OPG,在N和T2D中降低RANKL,但在IR中增加。在T2D中,LRP5 / DKK1和LRP5 / SOST mRNA的比率类似地降低,但是在IR中,后者的比率降低而前者增加。在Ex-4之后,两个比率的N均增加,而LRP5 / DKK1的比率在T2D和IR中趋于正常。总之,Ex-4在T2D和IR模型中发挥成骨作用,并与Wnt途径相互作用以促进骨形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号